Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: FastC6 who wrote (912)	4/1/2000 5:00:00 PM
From: James Strauss	Respond to of 1018

Snake: I'm happy your PC2000 investment is doing well... While I would like more detailed info from IFLO, I respect their decision to give broader product breakdowns... Here is a product line breakdown from their 10K Annual Report: Revenues by Market Segment 1999 1998 1997 -------------------------- ---- ---- ---- Hospital and Pain Management 26% 9% -- Home Care 25% 36% 64% Oncology 29% 27% -- International 20% 28% 36% The most dramatic growth is in the pain management area... Not surprisingly, the pick up in revenues and earnings coincides with this shift in focus... IFLO mgmt knows what it's doing, and the numbers prove it... freeedgar.com Jim